Aquaporin-2 and Nephrogenic Diabetes Insipidus Research Publication Trend The graph below shows the total number of publications each year in Aquaporin-2 and Nephrogenic Diabetes Insipidus Research.

Transient diabetes insipidus almost always begins within 24-48 h of surgery, and usually abates within several days. Both transient diabetes insipidus and the first phase of the triphasic pattern ...

How Australian pregnant women are tested for gestational diabetes is set to change, with new national guidelines released today. Changes are expected to lead to fewer diagnoses in women at lower ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after ...

Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an advanced stem cell therapy.

Finally, as a practical consideration, any patient with postoperative diabetes insipidus should be presumed to have anterior pituitary insufficiency as well, and should receive corticosteroid ...

The American College of Physicians (ACP) issued new A1C guidelines for people managing type 2 diabetes, drawing both criticism and praise. Here’s what to know about the new target range and what ...

Among the four diet types trialed in this study, a modified version of the DASH diet with reduced sodium intake achieved a better overall decrease in blood pressure in people with type 2 diabetes.

Weight loss and diabetes jabs taken by more than a million people in the UK have been linked to a potential serious side effect, with some deaths, according to data from the UK medicines regulator.

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed.

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management.

Ten people have been effectively cured of their type 1 diabetes after a breakthrough infusion of a new treatment on the path toward FDA approval.